Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1966 May;28(3):331–334. doi: 10.1136/hrt.28.3.331

Haemodynamic effects of dipyridamole at rest and during exercise in healthy subjects.

G A Bousvaros, J E Campbell, M McGregor
PMCID: PMC487877  PMID: 4957003

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOUSVAROS G. A., PALMER W. H., SEKELJ P., McGREGOR M. Comparison of central and peripheral injection sites in the estimation of cardiac output by dye dilution curves. Circ Res. 1963 Mar;12:317–321. doi: 10.1161/01.res.12.3.317. [DOI] [PubMed] [Google Scholar]
  2. FAM W. M., MCGREGOR M. EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA. Circ Res. 1964 Oct;15:355–364. doi: 10.1161/01.res.15.4.355. [DOI] [PubMed] [Google Scholar]
  3. FOULDS T., MACKINNON J. Controlled double-blind trial of "persantin" in treatment of angina pectoris. Br Med J. 1960 Sep 17;2(5202):835–835. doi: 10.1136/bmj.2.5202.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GEBHARDT W., DRESSEL J., STEIM H., REINDELL H. [Action of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine on the circulation]. Arzneimittelforschung. 1961 Oct;11:962–969. [PubMed] [Google Scholar]
  5. GORLIN R., BRACHFELD N., MACLEOD C., BOPP P. Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation. 1959 May;19(5):705–718. doi: 10.1161/01.cir.19.5.705. [DOI] [PubMed] [Google Scholar]
  6. HOLMGREN A., OVENFORS C. O. Heart volume at rest and during muscular work in the supine and in the sitting position. Acta Med Scand. 1960 Jul 15;167:267–277. doi: 10.1111/j.0954-6820.1960.tb03546.x. [DOI] [PubMed] [Google Scholar]
  7. Hoeschen R. J., Bousvaros G. A., Klassen G. A., Fam W. M., McGregor M. Haemodynamic effects of angina pectoris, and of nitroglycerin in normal and anginal subjects. Br Heart J. 1966 Mar;28(2):221–230. doi: 10.1136/hrt.28.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KADATZ R. Die pharmakologischen Eigenschaften der neuen coronarerweiternden Substanz 2,6-Bis(diaethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d)pyrimidin. Arzneimittelforschung. 1959 Jan;9(1):39–45. [PubMed] [Google Scholar]
  9. KINSELLA D., TROUP W., McGREGOR M. Studies with a new coronary vasodilator drug: persantin. Am Heart J. 1962 Feb;63:146–151. doi: 10.1016/0002-8703(62)90190-4. [DOI] [PubMed] [Google Scholar]
  10. SARNOFF S. J., BRAUNWALD E., WELCH G. H., Jr, CASE R. B., STAINSBY W. N., MACRUZ R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol. 1958 Jan;192(1):148–156. doi: 10.1152/ajplegacy.1957.192.1.148. [DOI] [PubMed] [Google Scholar]
  11. SOLOFF L. A., GIMENEZ J. L., WINTERS W. L., Jr Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin). Am J Med Sci. 1962 Jun;243:783–789. doi: 10.1097/00000441-196206000-00009. [DOI] [PubMed] [Google Scholar]
  12. WENDT V. E., SUNDERMEYER J. F., DENBAKKER P. B., BING R. J. The relationship between coronary blood flow, myocardial oxygen consumption and cardiac work as influenced by persantin. Am J Cardiol. 1962 Mar;9:449–454. doi: 10.1016/0002-9149(62)90162-5. [DOI] [PubMed] [Google Scholar]
  13. WEST J. W., BELLET S., MANZOLI U. C., MUELLER O. F. Effects of Persantin (RA8), a new coronary vasodilator, on coronary blood flow and cardiac dynamics in the dog. Circ Res. 1962 Jan;10:35–44. doi: 10.1161/01.res.10.1.35. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES